Medicare AdvantagePrior AuthMedium impact
Enbumyst (bumetanide) (New)
Humana·Cardiology, Nephrology, Internal Medicine +2 more·Medicare Advantage
Effective date
Jan 28, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Enbumyst (bumetanide nasal spray) effective January 28, 2026. Patients must have congestive heart failure, hepatic disease, or renal disease with edema and must have tried oral loop diuretics first.
Action Required
By January 28, 2026: Billing team must update prior authorization workflows for Enbumyst (bumetanide nasal spray) prescriptions for Humana Medicare Advantage patients. Providers must document diagnosis of congestive heart failure, hepatic disease, or renal disease with edema, plus previous treatment with oral loop diuretics like furosemide. Submit prior authorization requests through www.humana.com/PAL. Claims will be denied without proper prior authorization.